Core Viewpoint - eBay shares have increased by approximately 7.5% since the last earnings report, outperforming the S&P 500, raising questions about the sustainability of this positive trend leading up to the next earnings release [1] Group 1: Earnings Report Insights - Recent earnings report indicates that estimates for eBay have trended upward over the past month, suggesting positive momentum [2] - The stock has a strong Growth Score of A, but a lower Momentum Score of C, and a Value Score of C, placing it in the middle 20% for the value investment strategy [3] Group 2: Future Outlook - The upward trend in estimates is promising, and eBay holds a Zacks Rank of 3 (Hold), indicating expectations for an in-line return in the coming months [4]

Company Overview - Tandem Diabetes Care, Inc. (TNDM) has seen its shares increase by approximately 6.5% over the past month, outperforming the S&P 500 [1] - The most recent earnings report is crucial for understanding the key drivers affecting the stock [1] Earnings Estimates - Estimates for Tandem Diabetes Care have trended downward over the past month, with the consensus estimate shifting by -19.45% [2] - The stock currently holds a Zacks Rank of 3 (Hold), indicating expectations for an in-line return in the coming months [4] VGM Scores - Tandem Diabetes Care has an average Growth Score of C, a Momentum Score of F, and a Value Score of C, placing it in the middle 20% for the value investment strategy [3] - The overall aggregate VGM Score for the stock is D, which is significant for investors not focused on a single strategy [3] Industry Performance - Tandem Diabetes Care is part of the Zacks Medical - Instruments industry, where another player, Intuitive Surgical, Inc. (ISRG), has gained 7.5% in the past month [5] - Intuitive Surgical reported revenues of $2.25 billion for the last quarter, reflecting a year-over-year increase of +19.2% [5] - The expected earnings for Intuitive Surgical in the current quarter are $1.92 per share, indicating a +7.9% change from the previous year [6]

A month has gone by since the last earnings report for Paypal (PYPL) . Shares have added about 8.5% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Paypal due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.How Have Estimates Been Moving Since Then?It turns out, fresh es ...

Core Viewpoint - Universal Health Services (UHS) shares have increased by approximately 12% over the past month, outperforming the S&P 500, raising questions about the sustainability of this trend leading up to the next earnings release [1] Estimates Movement - Estimates for Universal Health Services have trended upward over the past month, indicating positive sentiment among analysts [2] VGM Scores - Universal Health Services currently holds a strong Growth Score of A, a Momentum Score of B, and a Value Score of A, placing it in the top 20% for the value investment strategy, resulting in an aggregate VGM Score of A [3] Outlook - The upward trend in estimates suggests a promising outlook for Universal Health Services, which currently has a Zacks Rank of 3 (Hold), indicating expectations for an in-line return in the coming months [4] Industry Performance - Universal Health Services is part of the Zacks Medical - Hospital industry, where HCA Healthcare has gained 11.2% over the past month, reporting revenues of $18.32 billion for the last quarter, reflecting a year-over-year increase of 5.7% [5] - HCA is projected to report earnings of $6.20 per share for the current quarter, representing a year-over-year change of 12.7%, with the Zacks Consensus Estimate remaining unchanged over the last 30 days, also holding a Zacks Rank of 3 (Hold) and a VGM Score of A [6]

Core Viewpoint - Boston Scientific shares have increased by approximately 3.3% over the past month, underperforming the S&P 500 index [1] Group 1: Earnings and Estimates - Estimates for Boston Scientific have trended upward in the past month, indicating positive sentiment among analysts [2] - The most recent earnings report highlighted important drivers for the stock's performance [1] Group 2: VGM Scores - Boston Scientific has a Growth Score of B, a Momentum Score of C, and a Value Score of D, placing it in the bottom 40% for the value investment strategy [3] - The aggregate VGM Score for Boston Scientific is C, which is relevant for investors not focused on a single strategy [3] Group 3: Outlook - The upward trend in estimates suggests a promising outlook for Boston Scientific, with a Zacks Rank of 3 (Hold), indicating an expectation of in-line returns in the coming months [4] Group 4: Industry Performance - Boston Scientific is part of the Zacks Medical - Products industry, where Abbott has gained 1.6% over the past month [5] - Abbott reported revenues of $10.36 billion for the last quarter, reflecting a year-over-year increase of 4%, with EPS rising from $0.98 to $1.09 [5] - For the current quarter, Abbott is expected to post earnings of $1.25 per share, representing a 9.7% increase from the previous year [6]

Core Viewpoint - RPM International's shares have increased by approximately 3.5% over the past month, outperforming the S&P 500, but there are concerns about a potential pullback as estimates have trended downward leading up to the next earnings release [1]. Group 1: Earnings Report and Market Reaction - The most recent earnings report indicated a positive trend in share performance, but the consensus estimate has shifted downward by 9.66% in the past month [2]. - Investors and analysts are closely monitoring the stock's performance as the next earnings release approaches [1]. Group 2: VGM Scores and Investment Strategy - RPM International has an average Growth Score of C, a Momentum Score of F, and a Value Score of D, placing it in the bottom 40% for the value investment strategy [3]. - The overall aggregate VGM Score for the stock is D, suggesting a lack of strong performance across multiple investment strategies [3]. Group 3: Outlook and Future Expectations - The downward trend in estimates indicates a negative outlook for RPM International, reflected in its Zacks Rank of 4 (Sell) [4]. - The expectation is for below-average returns from the stock in the upcoming months [4].